BioLineRx Ltd. (NASDAQ:BLRX) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2023 Financial Results Conference Call.

Related Keywords

China ,Israel ,Mali ,Kevin Campbell ,Phil Serlin ,Eric Sapp ,Mark Breidenbach ,Genzyme Sanofi ,Joe Pantginis ,John Lacey ,Ella Sorani ,Tami Rachmilewitz ,Philip Serlin ,John Vandermosten ,Nasdaq ,Corporate Communications Biolinerx ,Washington University School Of Medicine ,Columbia University ,Market Development ,Program Scientific Advisory Board ,Biolinerx Ltd ,Call Transcript May ,Biolinerx First Quarter ,Results Conference ,Investor Relations ,Corporate Communications ,Chief Executive Officer ,Mali Zeevi ,Chief Financial Officer ,Chief Development Officer ,Holly May ,Biolinerx United States ,Chief Medical ,Genesis Phase ,Washington University School ,Genfleet Therapeutics ,Combination Study ,Genfleet Phase ,Kreos Capital ,